Leases

3 Months Ended

Mar. 31, 2019

5. Leases

The Company has entered into operating leases primarily for commercial buildings. These leases have terms which range from 2 years to 8 years, some of which include options to extend the leases for up to 5 years. There are no economic penalties for the Company to extend the lease, and it is not reasonably assured that the Company will exercise the extension options. Based on the present value of the lease payments for the remaining lease term of the Company's existing leases, the Company recognized operating lease right-of-use assets and operating lease liabilities of $6,418 on January 1, 2019. Operating lease right-of-use assets and liabilities commencing after January 1, 2019 are recognized at commencement date based on the present value of lease payments over the lease term. The operating leases do not contain material residual value guarantees or material restrictive covenants.

As a result of the MedSupport acquisition, the Company leases a property owned by a related party. Operating lease cost for the property was $8 for the three months ended March 31, 2019, which is included in the total operating lease cost.

Information related to the Company's right-of-use assets and related operating lease liabilities were as follows:

	Three months ended March 31, 2019
Cash paid for operating lease liabilities	$	576
Operating lease cost		544
Non-cash right-of-use assets obtained in exchange for new operating lease obligations		6,418
Weighted-average remaining lease term	3.1 years
Weighted-average discount rate		3.8	%

Maturities of lease liabilities due in the 12 month period ending March 31,
2020	$	2,289
2021		1,750
2022		1,246
2023		937
2024		902
Thereafter		453
		7,577
Less imputed interest		(596	)
Total lease liabilities	$	6,981

Current operating lease liabilities	$	2,061
Operating lease liabilities - noncurrent		4,920
Total lease liabilities	$	6,981